Meningococcal sepsis complicating eculizumab treatment despite prior vaccination. - Wikidata - awgldk - TriplyDB

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

http://www.wikidata.org/entity/Q44204666

about

Meningococcal Vaccinations Advances and challenges in the management of complement-mediated thrombotic microangiopathies Monoclonal antibody therapy and renal transplantation: focus on adverse effects Complement cascade and kidney transplantation: The rediscovery of an ancient enemy A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.An international consensus approach to the management of atypical hemolytic uremic syndrome in children.Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.Atypical Hemolytic Uremic Syndrome: A Brief Review.Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.Meningococcal disease and the complement system.Central nervous system syndromes in solid organ transplant recipients.Immunization after kidney transplantation-what is necessary and what is safe?Advances in pharmacotherapy to treat kidney transplant rejection.Complement inhibition as potential new therapy for antibody-mediated rejection.An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment.Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed.A Case of Fulminant Meningococcemia: It Is All in the Complement.Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies.Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.Vaccinations in children on immunosuppressive medications for renal disease.Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.Thrombotic Microangiopathy and the Kidney.Waterhouse-Friderichsen syndrome due to Neisseria meningitidis infection in a young adult with thrombotic microangiopathy and eculizumab treatment: case report and review of management.Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations.

P2860

Q26752993-A7445CE5-FDC7-4912-ABBC-1C276AAFFA3E Q26796453-C37B1844-4E94-4712-8FCB-AE6DEF8FF45B Q26826880-1B75C09B-07C1-4EA2-BE87-BB46BC208708 Q26829790-58719DAE-5E65-4077-8237-61CC76D07D39 Q28661698-1550AD4F-AEA2-49A1-AD50-1427E935F887 Q33417375-6C49760F-61F5-4980-B22B-65A769B80EF8 Q33421861-1EE9DD87-C508-49CC-B0BB-3F170078B933 Q33430681-CBF52A61-2023-4A0B-839D-0C46728A5433 Q33430817-75B3A875-778A-49A1-B22E-8D3B36E8AB56 Q33442794-3BA44D39-B52B-4698-9517-B794BAD8F25A Q33783126-57EEC337-570F-467A-8940-D7E1C1362438 Q34376170-D2BACC7A-5E92-4F10-8945-4C453BB8C57C Q38219391-32091C30-61EE-4B2B-98D6-65727179BFD9 Q38235003-B8D9C30C-00D9-40D0-8691-0A1F692469B6 Q38544529-5A3C53F9-75E6-4C72-BE46-74AE44F25783 Q38609238-F5E6B204-31FC-44D5-A37C-2A3EFB43A2F1 Q38775024-93CB9B62-C49E-4B5F-B741-D970AB6AE349 Q38806679-4104F6ED-E28E-48A8-86FA-E5D5F201109C Q38907049-E195840E-6AFD-4E04-A5FB-B94801BEA7ED Q38998217-772BB65B-62EC-40D7-A0A1-21DC6B06DD7C Q40093163-404C4F2A-0199-4A32-9505-7B0FA2D61429 Q40268126-DEAA482E-F6AA-4278-9251-2FC0162C47F0 Q40722182-2C197DD4-FD86-436A-A4C0-97AA0F5A9FCE Q40960257-1CF54F7A-38C0-46D9-A94A-CF85DCE7E4A4 Q41488993-CF2829BD-91BF-439F-9F3A-E7FD159F38FB Q42086661-1122DFA2-DC66-4E0E-9837-D38E5F62AED8 Q48255838-AA952BE5-9B09-4A2B-9E47-F8B3B949DB26 Q50085453-DEB57296-E1E0-4F25-AB65-C1395D024AFC Q54432568-7A1FB66C-2335-4DC5-9387-629F492D5BEE Q55505646-111F30AF-A9A8-43B1-8DD0-92BEA612891E

P2860

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

http://www.wikidata.org/entity/Q44204666

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@en

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@nl

type

label

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@en

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@nl

prefLabel

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@en

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@nl

P1433

Q44204666-50639860-D3AD-4C41-94E9-7D125E6F1E25

P1476

Q44204666-A3E080B2-FF13-4CFB-894A-621E82D46EF6

P2093

Q44204666-6C6C8CDF-F832-43F7-AE13-B79F18E16BA8

Q44204666-6D42C4FD-266D-456F-9DF5-98AC036AFF54

Q44204666-720BB079-F539-4DB2-A740-D7662ADF4EF5

Q44204666-8258F073-0CBC-46CA-94C4-1AC1DB739EF2

Q44204666-9FF80643-0831-4C35-A103-9B6A3B54F902

Q44204666-C262DFA1-5975-4D95-A07B-4C456F190781

P2860

Q44204666-119D42F2-65F4-435E-9C9F-FAF8AD13B249

Q44204666-13D5A5DA-3B8A-4542-8134-9EFD8A839EF5

Q44204666-2A0B4390-C6D1-48BA-9ACD-C516655DF16A

Q44204666-30B179F9-1388-4860-ACB1-CE221102B3FD

P304

Q44204666-0B5FE987-83FA-4EF2-8A2D-E73130062F41

P31

Q44204666-60D205D6-B56B-4A10-BAFA-A272330A4344

P356

Q44204666-AE06FDDC-A7B4-4777-9198-60BEEF9FD4BB

P407

Q44204666-1574CE14-1DB4-4D63-A393-EA9489BC4D11

P433

Q44204666-6B79636A-0AC4-4813-B3C8-9CEDF9D542C9

P478

Q44204666-E7FDB256-A0ED-4F4B-8B7A-FB5C2F345670

P577

Q44204666-A5C2EBCE-7526-4296-8EA6-633DC8A0718F

P5875

Q44204666-5860EF0E-99E2-4908-8054-660BC95A3E42

P698

Q44204666-F4B3C79F-AE7B-4F15-AAC9-9D0C699F1DAF

P356

P1433

American Journal of Transplantation

P1476

Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.

@en

P2093

A H M Bouts

http://www.w3.org/2001/XMLSchema#string

E A C Kuin

http://www.w3.org/2001/XMLSchema#string

F J Bemelman

http://www.w3.org/2001/XMLSchema#string

G H Struijk

http://www.w3.org/2001/XMLSchema#string

G T Rijkers

http://www.w3.org/2001/XMLSchema#string

I J M ten Berge

http://www.w3.org/2001/XMLSchema#string

P2860

Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy

Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.

Effect of rituximab on human in vivo antibody immune responses.

Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.

P304

819-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12032

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234068142

http://www.w3.org/2001/XMLSchema#string

P698

23289494

http://www.w3.org/2001/XMLSchema#string